150 related articles for article (PubMed ID: 37663384)
21. Ginsenoside Rg1 abolish imiquimod-induced psoriasis-like dermatitis in BALB/c mice via downregulating NF-κB signaling pathway.
Shi Q; He Q; Chen W; Long J; Zhang B
J Food Biochem; 2019 Nov; 43(11):e13032. PubMed ID: 31502279
[TBL] [Abstract][Full Text] [Related]
22. An Emerging Role of
Yang Y; Zhao Y; Lai R; Xian L; Lei Q; Xu J; Guo M; Xian D; Zhong J
Oxid Med Cell Longev; 2022; 2022():5800586. PubMed ID: 35720176
[TBL] [Abstract][Full Text] [Related]
23. Protective effects of ambroxol in psoriasis like skin inflammation: Exploration of possible mechanisms.
Sunkari S; Thatikonda S; Pooladanda V; Challa VS; Godugu C
Int Immunopharmacol; 2019 Jun; 71():301-312. PubMed ID: 30933843
[TBL] [Abstract][Full Text] [Related]
24. Anti-IL-17A ssDNA aptamer ameliorated psoriasis skin lesions in the imiquimod-induced psoriasis mouse model.
Shobeiri SS; Rezaee M; Pordel S; Haghnnavaz N; Dashti M; Moghadam M; Sankian M
Int Immunopharmacol; 2022 Sep; 110():108963. PubMed ID: 35724603
[TBL] [Abstract][Full Text] [Related]
25. Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in mice.
Liu Z; Liu H; Xu P; Yin Q; Wang Y; Opoku YK; Yang J; Song L; Sun X; Zhang T; Yu D; Wang X; Ren G; Li D
Biomed Pharmacother; 2018 Dec; 108():1425-1434. PubMed ID: 30372845
[TBL] [Abstract][Full Text] [Related]
26. Indirubin combined with umbilical cord mesenchymal stem cells to relieve psoriasis-like skin lesions in BALB/c mice.
Lu X; Wang H; Wang H; Xie F; Jiang C; Shen D; Zhang H; Yang J; Lin Y
Front Immunol; 2022; 13():1033498. PubMed ID: 36466901
[TBL] [Abstract][Full Text] [Related]
27. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
[TBL] [Abstract][Full Text] [Related]
28. Cimifugin ameliorates imiquimod-induced psoriasis by inhibiting oxidative stress and inflammation via NF-κB/MAPK pathway.
Liu A; Zhao W; Zhang B; Tu Y; Wang Q; Li J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32515468
[TBL] [Abstract][Full Text] [Related]
29. IL-23/IL-17 immune axis mediates the imiquimod-induced psoriatic inflammation by activating ACT1/TRAF6/TAK1/NF-κB pathway in macrophages and keratinocytes.
Chen WC; Wen CH; Wang M; Xiao ZD; Zhang ZZ; Wu CL; Wu R
Kaohsiung J Med Sci; 2023 Aug; 39(8):789-800. PubMed ID: 37098777
[TBL] [Abstract][Full Text] [Related]
30. Natural product topical therapy in mitigating imiquimod-induced psoriasis-like skin inflammation-underscoring the anti-psoriatic potential of Nimbolide.
More NB; Sharma N; Pulivendala G; Bale S; Godugu C
Indian J Pharmacol; 2021; 53(4):278-285. PubMed ID: 34414905
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis.
Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ
Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833
[TBL] [Abstract][Full Text] [Related]
32. Tranexamic acid improves psoriasis-like skin inflammation: Evidence from in vivo and in vitro studies.
Hseu JH; Chan CI; Vadivalagan C; Chen SJ; Yen HR; Hseu YC; Yang HL; Wu PY
Biomed Pharmacother; 2023 Oct; 166():115307. PubMed ID: 37573659
[TBL] [Abstract][Full Text] [Related]
33. Fufang Shengdi mixture alleviates psoriasis-like skin inflammation via promoting Annexin-A proteins expression.
Zhou X; Lyu C; Chen X; Ye Y; Lei Y; Liu Y; Zhang T; Yang Y
J Ethnopharmacol; 2023 Aug; 312():116329. PubMed ID: 36940737
[TBL] [Abstract][Full Text] [Related]
34. The Essential Oil Derived from
Xu Y; Shi Y; Huang J; Gu H; Li C; Zhang L; Liu G; Zhou W; Du Z
Molecules; 2022 May; 27(9):. PubMed ID: 35566346
[TBL] [Abstract][Full Text] [Related]
35. IL-27 activates Th1-mediated responses in imiquimod-induced psoriasis-like skin lesions.
Shibata S; Tada Y; Asano Y; Yanaba K; Sugaya M; Kadono T; Kanda N; Watanabe S; Sato S
J Invest Dermatol; 2013 Feb; 133(2):479-88. PubMed ID: 22951728
[TBL] [Abstract][Full Text] [Related]
36. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
[TBL] [Abstract][Full Text] [Related]
37. Development of a psoriatic-like skin inflammation rat model using imiquimod as an inducing agent.
Parmar KM; Jagtap CS; Katare NT; Dhobi M; Prasad SK
Indian J Pharmacol; 2021; 53(2):125-131. PubMed ID: 34100396
[TBL] [Abstract][Full Text] [Related]
38. [Effect of fire needling on imiquimod induced psoriasis-like lesion and STAT3 pathway in mice].
Feng F; Wang Y; Zhao JX; Di TT; Meng YJ; Chen ZX; Qi C; Hu XQ; Wang YZ; Li P
Zhongguo Zhen Jiu; 2022 May; 42(5):541-8. PubMed ID: 35543945
[TBL] [Abstract][Full Text] [Related]
39. Elevated cholesteryl ester transfer and phospholipid transfer proteins aggravated psoriasis in imiquimod-induced mouse models.
Chen J; Qi H; Liu L; Niu Y; Yu S; Qin S; He L
Lipids Health Dis; 2022 Aug; 21(1):75. PubMed ID: 35982498
[TBL] [Abstract][Full Text] [Related]
40. Development and evaluation emulgel for effective management of the imiquimod-induced psoriasis.
Sulthana S; Chary PS; Bhavana V; Pardhi E; Singh SB; Mehra NK
Inflammopharmacology; 2023 Feb; 31(1):301-320. PubMed ID: 36609718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
